Patent analysis software advances freedom-to-operate

Genedata, announces the release of PatentExplorer, an interdisciplinary software tool for assessing the patent situation of novel biomolecules and targets.

Part of the Genedata Phylosopher biological data management system, PatentExplorer integrates patent information to provide a comprehensive and structured analysis of patented biomolecule sequences, related claim information, and freedom-to-operate.

This facilitates intellectual property evaluation from both a business and a biological standpoint. It was developed in close collaboration with DSM.

"Today's industrial biotechnology market is driven by innovation. Securing the intellectual property of life science research at DSM is crucial in order to retain a competitive advantage," explained Dr Wim de Boer, intellectual assets manager at DSM. "We chose Genedata to help us develop an integrated platform to manage our project intellectual property information because Genedata has significant scientific, technical and business experience and this has been a key factor in the success of this joint development project."

"PatentExplorer integrates directly into DSM's global genome sequence information management system, which is based on the Genedata Phylosopher software platform," said Dr Hans Roubos, senior scientist bioinformatics at DSM. "It provides direct access to the most recent patent information in the context of DSM's in-house genomics research data, which gives much appreciated transparency to decision making."

PatentExplorer's primary applications are in the development of novel enzymes and engineered proteins, as well as freedom-to-operate assessment support. The software can handle commercial data sources as well as publicly available patent information.